- Home
- HSCS vs PRSO Comparison
HSCS vs PRSO Comparison
Compare HSCS & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- PRSO
- Stock Information
- Founded
- HSCS 2007
- PRSO 2008
- Country
- HSCS United States
- PRSO United States
- Employees
- HSCS N/A
- PRSO N/A
- Industry
- HSCS Medical Specialities
- PRSO Semiconductors
- Sector
- HSCS Health Care
- PRSO Technology
- Exchange
- HSCS Nasdaq
- PRSO Nasdaq
- Market Cap
- HSCS 2.8M
- PRSO 3.3M
- IPO Year
- HSCS 2022
- PRSO 2001
- Fundamental
- Price
- HSCS $3.30
- PRSO $0.70
- Analyst Decision
- HSCS Strong Buy
- PRSO Strong Buy
- Analyst Count
- HSCS 2
- PRSO 2
- Target Price
- HSCS $13.00
- PRSO $3.38
- AVG Volume (30 Days)
- HSCS 8.7K
- PRSO 74.6K
- Earning Date
- HSCS 03-13-2025
- PRSO 05-12-2025
- Dividend Yield
- HSCS N/A
- PRSO N/A
- EPS Growth
- HSCS N/A
- PRSO N/A
- EPS
- HSCS N/A
- PRSO N/A
- Revenue
- HSCS N/A
- PRSO $14,573,000.00
- Revenue This Year
- HSCS N/A
- PRSO $3.74
- Revenue Next Year
- HSCS N/A
- PRSO $37.09
- P/E Ratio
- HSCS N/A
- PRSO N/A
- Revenue Growth
- HSCS 261.17
- PRSO 5.99
- 52 Week Low
- HSCS $2.36
- PRSO $0.52
- 52 Week High
- HSCS $13.50
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- HSCS 55.49
- PRSO 49.46
- Support Level
- HSCS $2.97
- PRSO $0.59
- Resistance Level
- HSCS $3.83
- PRSO $0.69
- Average True Range (ATR)
- HSCS 0.28
- PRSO 0.07
- MACD
- HSCS 0.06
- PRSO 0.01
- Stochastic Oscillator
- HSCS 56.20
- PRSO 75.00
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.